Skip to main content
PMC home page
Nature Communications logoLink to Nature Communications
. 2019 Nov 15;10:5257. doi: 10.1038/s41467-019-13151-z

Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer

Katherine A Michaelis 1,2, Mason A Norgard 3, Xinxia Zhu 3, Peter R Levasseur 3, Shamilene Sivagnanam 4, Shannon M Liudahl 5, Kevin G Burfeind 1, Brennan Olson 1, Katherine R Pelz 3, Diana M Angeles Ramos 3, H Carlo Maurer 6, Kenneth P Olive 6, Lisa M Coussens 5, Terry K Morgan 7, Daniel L Marks 2,3,✉
PMCID: PMC6858433  PMID: 31729370

Correction to: Nature Communications 10.1038/s41467-019-12657-w, published online 15 October 2019.

The original HTML and PDF of this Article contained errors in Figs. 3 and 4. All panels for Figures 3 and 4 were inadvertently inverted. This has been corrected in both the HTML and PDF versions of the Article.

Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES